DCF ADVISERS, LLC – Intra-Cellular Therapies, Inc. Transaction History
DCF ADVISERS, LLC portfolio value:
$7.72M
portfolio value
DCF ADVISERS, LLC quarter portfolio value change:
-18.48%
quarter
Intra-Cellular Therapies, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -19.65% | -40.58K shares | -4.06M | $46.53 | 165.99K |
Q2 2022 | share | Decrease | -13.38% | -31.91K shares | -2.80M | $57.08 | 206.58K |
Q1 2022 | share | Decrease | -33.57% | -120.5K shares | -4.19M | $61.19 | 238.5K |
Q4 2021 | share | Decrease | -5.28% | -20K shares | 4.66M | $52.13 | 359K |
Q3 2021 | share | Increase | +1.07% | 4K shares | -1.17M | $37.28 | 379K |
Q2 2021 | share | Decrease | -11.66% | -49.5K shares | 905K | $40.82 | 375K |
Q1 2021 | share | 0.00% | 0 shares | 904K | $33.93 | 424.5K | |
Q4 2020 | share | Decrease | -0.59% | -2.5K shares | 2.54M | $31.8 | 424.5K |
Q3 2020 | share | Increase | +0.35% | 1.5K shares | 34K | $25.66 | 427K |
Q2 2020 | share | Decrease | -1.62% | -7K shares | 4.27M | $25.67 | 425.5K |
Q1 2020 | share | Decrease | -7.60% | -35.57K shares | -9.41M | $15.37 | 432.5K |
Q4 2019 | share | Increase | 0.00% | 468.07K shares | 16.06M | $34.31 | 468.07K |